|
|
Compass Online
Introduction
Ocular allergies are extremely common, affecting up to 80 million people
in the U.S. Allergic conjunctivitis alone is estimated to impact nearly
25% of the population. Yet few continuing medical educational programs
have focused on ocular allergies. In an effort to bridge this gap, the
AAAAI brought together a diverse team of healthcare experts to develop
Compass: New Directions in the Treatment of Allergic Conjunctivitis and
Related Disorders. The information presented in Compass will help
primary healthcare professionals explore and develop appropriate
diagnosis, treatment and management plans that can enhance the quality
of life for their patients who suffer from ocular allergies.
Acknowledgements
Compass was originally presented as an interactive 3-hour, continuing
medical education (CME) credit-bearing dinner seminar, supported through
an unrestricted educational grant from Alcon Laboratories.
[
proceed to Overview ]
|
Contact
Home
